However, the anti-RAGE antibody suppressed the CML-mediated dysregulation of SREBP-2, HMG-CoAR, LDLr, LXR, and ABCA1 (Figures 4(a) and 4(b)). The gene discussed is SREBF2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.